A young girl in India has received a life-saving Zolgensma injection worth approximately Rs 160 million, offering a new chance at life.
The child was diagnosed with Spinal Muscular Atrophy Type 1 (SMA Type 1), a rare genetic disorder that causes severe muscle weakness and loss of movement. Due to the extremely high cost of treatment, her family initially could not afford the injection.
Hope emerged when a crowdfunding campaign was launched after a newspaper report highlighted the family’s struggle. People from across the country came forward with generous donations, helping raise nearly Rs 10 crore. Additional contributions and support were arranged to complete the required amount.
Doctors administered the Zolgensma injection, a groundbreaking gene therapy designed to treat SMA by targeting its root genetic cause. Early treatment is considered critical for improving survival rates and overall quality of life.
The girl’s parents said they noticed reduced physical activity just months after her birth. Medical tests later confirmed the condition, leaving the family devastated. However, doctors assured them that timely treatment could make a significant difference.
Andhra Pradesh Minister Nara Lokesh also extended support by helping facilitate the import of the injection from abroad.
Health experts emphasise that early diagnosis and access to advanced treatments like the Zolgensma injection can dramatically improve outcomes for children suffering from SMA Type 1.